Picture of the Week and Clinical Case Presentations: CCBD Management Rounds

  • To apply the principles of evidence-based medicine in the diagnosis and work-up of children with hematological and oncological diseases
  • To design and apply a treatment plan for patients with hematological and oncological diseases
  • To evaluate and manage the treatment and potential complications patients with complex hematological and oncological disorders experience

Guest Speaker: Management of Cytomegalovirus in 2025, has anything changed?

  • Summarize current antiviral options for CMV in pediatric oncology and transplant patients, including dosing and toxicity considerations
  • Describe emerging therapies for resistant or refractory CMV, such as letermovir, maribavir, and adoptive T-cell therapy
  • Review updated guideline recommendations for prophylaxis and treatment of CMV in pediatric oncology care

 

Session date: 
10/02/2025 - 1:00pm to 3:00pm EDT
Location: 
Children's National Hospital
111 Michigan Avenue NW
Washington, DC 20010
United States
See map: Google Maps
Add to calendar: 
  • 2.00 AMA PRA Category 1 Credit™
    Children’s National Hospital designates this Live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 2.00 ANCC
    Children’s National Hospital will provide 2.00 Nursing Contact Hours for this Live activity.
  • 2.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.
Faculty List: 
Course Director(s)

Liny John, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Benjamin Hanisch, M.D.

has no relevant financial relationships to disclose at this time.